However, recent reports indicate that overexpression of PPARγ2 specifically in pancreatic β Cells impaired insulin signaling and insulin secretion, exacerbated obesity-induced glucose intolerance and reduced β cell mass (29, 30). Here, INS is linked to obesity disorder.